Targeting the “Sweet Side” of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis

Targeting the “Sweet Side” of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis

Nanotechnology is in the spotlight of therapeutic innovation, with numerous advantages for tumor visualization and eradication. The end goal of the therapeutic use of nanoparticles, however, remains distant due to the limitations of nanoparticles to target cancer tissue. The functionalization of nan...

Full description

Bibliographic Details
Main Authors: Nora Bloise, Mohammad Okkeh, Elisa Restivo, Cristina Della Pina, Livia Visai
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Nanomaterials
Subjects:
aberrant glycosylation
glycan-binding molecules
lectin
antibody
tumor targeting and therapy
nanomedicine
Online Access:https://www.mdpi.com/2079-4991/11/2/289

Internet

https://www.mdpi.com/2079-4991/11/2/289

Similar Items